TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹4,717 Cr | ₹5,425 Cr | ₹5,447 Cr | ₹4,415 Cr | ₹4,892 Cr |
What is the latest Total Current Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹4,717 Cr |
| Mar2024 | ₹5,425 Cr |
| Mar2023 | ₹5,447 Cr |
| Mar2022 | ₹4,415 Cr |
| Mar2021 | ₹4,892 Cr |
How is Total Current Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,717 Cr | -13.05 | |
| Mar2024 | ₹5,425 Cr | -0.40 | |
| Mar2023 | ₹5,447 Cr | 23.38 | |
| Mar2022 | ₹4,415 Cr | -9.74 | |
| Mar2021 | ₹4,892 Cr | - | |
Compare Total Current Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹144,375.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
| MANKIND PHARMA | ₹84,227.3 Cr | 2% | -0.6% | -16.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -0% |
-3% |
33.3% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses